-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : RBC CUTS TARGET PRICE TO $280 FROM $345

Reuters·10/30/2026 03:54:28

Please log in to view news